A carregar...
A Systematic Review of Practice Guidelines and Recommendations for Discontinuation of Cholinesterase Inhibitors in Dementia
Cholinesterase inhibitors (ChEI) are the primary pharmacological treatment for symptom management of Alzheimer’s disease (AD), but they carry known risks during long-term use, and do not guarantee clinical effects over time. The balance of risks and benefits may warrant discontinuation at different...
Na minha lista:
| Publicado no: | Am J Geriatr Psychiatry |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5817050/ https://ncbi.nlm.nih.gov/pubmed/29167065 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jagp.2017.09.027 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|